ESC Premium Access

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Congress Presentation

About the speaker

Doctor Ryohei Amiya

Osaka University, Osaka (Japan)
0 follower

5 more presentations in this session

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)


Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)


Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)


Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Iksan, KR)


Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Copenhagen, DK)


Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Doctor M. Proietti, Professor H. Jeong...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb